MM, Z., Q, Z., HJ, C., BY, J., LB, T., GL, J., . . . YL, W. (2025). Cerebrospinal fluid circulating tumor DNA profiling for risk stratification and matched treatment of central nervous system metastases. Nature medicine, 31(5), 1547. https://doi.org/10.1038/s41591-025-03538-5
Chicago Style (17th ed.) CitationMM, Zheng, et al. "Cerebrospinal Fluid Circulating Tumor DNA Profiling for Risk Stratification and Matched Treatment of Central Nervous System Metastases." Nature Medicine 31, no. 5 (2025): 1547. https://doi.org/10.1038/s41591-025-03538-5.
MLA (9th ed.) CitationMM, Zheng, et al. "Cerebrospinal Fluid Circulating Tumor DNA Profiling for Risk Stratification and Matched Treatment of Central Nervous System Metastases." Nature Medicine, vol. 31, no. 5, 2025, p. 1547, https://doi.org/10.1038/s41591-025-03538-5.